SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-19-055585
Filing Date
2019-02-28
Accepted
2019-02-28 07:38:26
Documents
5
Effectiveness Date
2019-02-28

Document Format Files

Seq Description Document Type Size
1 S-3ASR d702076ds3asr.htm S-3ASR 271470
2 EX-5.1 d702076dex51.htm EX-5.1 16971
3 EX-23.1 d702076dex231.htm EX-23.1 1542
4 GRAPHIC g702076g0226191154946.jpg GRAPHIC 2293
5 GRAPHIC g702076g97p26.jpg GRAPHIC 29086
  Complete submission text file 0001193125-19-055585.txt   334564
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-229934 | Film No.: 19640477
SIC: 2834 Pharmaceutical Preparations